Founded in 1986, the well-known Dendrobium officinale brand is one of the earliest high-tech enterprises engaged in the cultivation, research and development, production and sales of Dendrobium officinale in China
Founded in 1986, Zhejiang Tianhuang Pharmaceutical Co., Ltd. is a high-tech enterprise engaged in the cultivation, research and development, production and sales of Dendrobium officinale in China, and is also a domestic manufacturer of Dendrobium officinale products that has passed the national GAP and GMP double certification.
In the early nineties, the company overcame the difficulties of artificial cultivation of the national rare and endangered medicinal material Dendrobium officinalis, filled the gaps at home and abroad, and created a large-scale Dendrobium officinalis imitation wild GAP base in China.
The company adheres to and advocates imitation wild planting according to the original ecological law of Dendrobium officinalis, using stone as the substrate to ensure a 6.5-year growth cycle, maintaining its medicinal properties to the greatest extent, and pioneering the establishment of a complete industrial chain from cell inoculation group cultivation seedlings, field cultivation of medicinal materials, processing and production of processed drugs, research and development, and drug sales, and establishing a whole-process quality control management system, realizing the standardization, scale, industrialization and modernization of traditional Chinese medicine production, and playing a benchmarking role in the entire Dendrobium industry.
In 1993, the company's independent research and development and production of "Lizuan" brand iron maple bucket granules (capsules) were successfully listed. Due to the remarkable effect of nourishing qi and nourishing yin, the curative effect is certain, and the applicable population is widespread, it has been popular in Jiangsu and Zhejiang as soon as it is listed, and the product has been in short supply. "Lizuan" brand iron maple bucket granules (capsules) is currently the national medicine quasi-brand class B over-the-counter drugs (OTC) among the current Dendrobium officinale products. Nowadays, Dendrobium plaster, Dendrobium drink, and maple lozenges have also been listed.
The company adheres to the tenet of "integrity management, quality first", and has been committed to expanding the cultivation area and production scale of Dendrobium officinalis, increasing investment in high-tech technology, constantly innovating and improving the extraction technology of Dendrobium officinale, and accelerating the development of Dendrobium officinale series products, so that more people can eat authentic, reliable and stable quality "standing diamond" maple bucket products.
